A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

Daxxify is different from Botox in that it works faster and for longer—most people will notice a major decrease in movement in two days with Daxxify, versus the usual 5-7 days with Botox, ...

A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...

Daxxify is a Botox alternative that smooths fine lines. Beauty director Brian Underwood tries the injectable and talks to experts about benefits, risks, and cost.

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.

Daxxify is the new neurotoxin injectable that lasts longer than its competitors like Botox and Dysport. Here's everything you need to know about it.

If Daxxify is intended to last twice as long as Botox, it would make sense that Daxxify would contain double the dose of the active ingredient (botulinum toxin type A) — but that isn’t the case.

Daxxify (daxibotulinumtoxinA) and Botox (onabotulinumtoxinA) are two neurotoxin brands used for cosmetic purposes, such as improving wrinkles or fine lines.

Daxxify is the longest-lasting neurotoxin, with effects lasting for an average of six months. It uses a peptide stabilizer instead of human serum albumin, and it’s a newer product, approved in ...